FDA Approves GSK ’s Voltaren Arthritis Pain for Over-the-Counter Use in the United States

Warren, New Jersey, USA  -- February 17, 2020 -- GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news